A recent Nature article reported that more than 70% of researchers have tried but failed to reproduce another scientist's experiments and more than half have failed to reproduce their own experiments. As a stakeholder in reproducibility issues it is important for antibody producers to ensure antibody quality and be transparent in their divulgence of antibody sources and validation processes. Read about Sino Biological's antibody validation process and how their design and QC procedures are done with reproducibility in mind.
Read Article